Checkpoint Inhibitor

  • Abstracts from the 4th ImmunoTherapy of Cancer Conference
    J. Ženka, V. Caisová, O. Uher, P. Nedbalová, K. Kvardová, K. Masáková, G. Krejčová, L. Paďouková, I. Jochmanová, K. I. Wolf, J. Chmelař, J. Kopecký, L. Loumagne, J. Mestadier, S. D’agostino, A. Rohaut, Y. Ruffin, V. Croize, O. Lemaître, S. S. Sidhu, S. Althammer, K. Steele, M. Rebelatto, T. Tan, T. Wiestler, A. Spitzmueller, R. Korn, G. Schmidt, B. Higgs, X. Li, L. Shi, X. Jin, K. Ranade, S. Koeck, A. Amann, G. Gamerith, M. Zwierzina, E. Lorenz, H. Zwierzina, J. Kern, M. Riva, T. Baert, A. Coosemans, R. Giovannoni, E. Radaelli, W. Gsell, U. Himmelreich, M. Van Ranst, F. Xing, W. Qian, C. Dong, X. Xu, S. Guo, Q. Shi, D. Quandt, B. Seliger, C. Plett, D. C. Amberger, A. Rabe, D. Deen, Z. Stankova, A. Hirn, Y. Vokac, J. Werner, D. Krämer, A. Rank, C. Schmid, H. Schmetzer, M. Guerin, J. M. Weiss, F. Regnier, G. Renault, L. Vimeux, E. Peranzoni, V. Feuillet, M. Thoreau, T. Guilbert, A. Trautmann, N. Bercovici, D. C. Amberger, F. Doraneh-Gard, C. L. Boeck, C. Plett, C. Gunsilius, C. Kugler, J. Werner, J. Schmohl, D. Kraemer, B. Ismann, A. Rank, C. Schmid, H. M. Schmetzer, A. Markota, C. Ochs, P. May, A. Gottschlich, J. Suárez Gosálvez, C. Karches, D. Wenk, S. Endres, S. Kobold, T. Hilmenyuk, R. Klar, F. Jaschinski, G. Gamerith, F. Augustin, E. Lorenz, C. Manzl, E. Hoflehner, P. Moser, B. Zelger, S. Köck, A. Amann, J. Kern, G. Schäfer, D. Öfner, H. Maier, H. Zwierzina, S. Sopper, H. Prado-Garcia, S. Romero-Garcia, R. Sandoval-Martínez, A. Puerto-Aquino, J. Lopez-Gonzalez, U. Rumbo-Nava, R. Klar, T. Hilmenyuk, F. Jaschinski, A. Coosemans, T. Baert, A. Van Hoylandt, P. Busschaert, I. Vergote, T. Baert, A. Van Hoylandt, P. Busschaert, I. Vergote, A. Coosemans, J. Laengle, K. Pilatova, E. Budinska, B. Bencsikova, R. Sefr, R. Nenutil, V. Brychtova, L. Fedorova, B. Hanakova, L. Zdrazilova-Dubska, Chris Allen, Yuan-Chieh Ku, Warren Tom, Yongming Sun, Alex Pankov, Tim Looney, Fiona Hyland, Janice Au-Young, Ann Mongan, A. Becker, J. B. L. Tan, A. Chen, K. Lawson, E. Lindsey, J. P. Powers, M. Walters, U. Schindler, S. Young, J. C. Jaen, S. Yin, Y. Chen, I. Gullo, G. Gonçalves, M. L. Pinto, M. Athelogou, G. Almeida, R. Huss, C. Oliveira, F. Carneiro, C. Merz, J. Sykora, K. Hermann, R. Hussong, D. M. Richards, H. Fricke, O. Hill, C. Gieffers, M. P. Pinho, J. A. M. Barbuto, S. E. McArdle, G. Foulds, J. N. Vadakekolathu, T. M. A. Abdel-Fatah, C. Johnson, S. Hood, P. Moseley, R. C. Rees, S. Y. T. Chan, A. G. Pockley, S. Rutella, C. Geppert, A. Hartmann, K. Senthil Kumar, M. Gokilavani, S. Wang, C. Merz, D. M. Richards, J. Sykora, M. Redondo-Müller, K. Heinonen, V. Marschall, M. Thiemann, H. Fricke, C. Gieffers, O. Hill, L. Zhang, B. Mao, Y. Jin, G. Zhai, Z. Li, Z. Wang, W. Qian, X. An, M. Qiao, J. Zhang, Q. Shi, J. Weber, H. Kluger, R. Halaban, M. Sznol, H. Roder, J. Roder, J. Grigorieva, S. Asmellash, C. Oliveira, K. Meyer, A. Steingrimsson, S. Blackmon, R. Sullivan, C. L. Boeck, D. C. Amberger, F. Doraneh-Gard, W. Sutanto, T. Guenther, J. Schmohl, F. Schuster, H. Salih, F. Babor, A. Borkhardt, H. Schmetzer, Y. Kim, I. Oh, C. Park, S. Ahn, K. Na, S. Song, Y. Choi, L. Fedorova, A. Poprach, R. Lakomy, I. Selingerova, R. Demlova, K. Pilatova, S. Kozakova, D. Valik, K. Petrakova, R. Vyzula, L. Zdrazilova-Dubska, D. Aguilar-Cazares, M. Galicia-Velasco, C. Camacho-Mendoza, L. Islas-Vazquez, R. Chavez-Dominguez, C. Gonzalez-Gonzalez, H. Prado-Garcia, J. S. Lopez-Gonzalez, S. Yang, K. D. Moynihan, M. Noh, A. Bekdemir, F. Stellacci, D. J. Irvine, B. Volz, K. Kapp, D. Oswald, B. Wittig, M. Schmidt, R. Chavez-Dominguez, D. Aguilar-Cazares, H. Prado-Garcia, L. Islas-Vazquez, J. S. Lopez-Gonzalez, R. Kleef, A. Bohdjalian, D. McKee, R. W. Moss, Mesha Saeed, Sara Zalba, Reno Debets, Timo L. M. ten Hagen, S. Javed, J. Becher, F. Koch-Nolte, F. Haag, E. M. Gordon, K. K. Sankhala, N. Stumpf, W. Tseng, S. P. Chawla, N. González Suárez, G. Bergado Báez, M. Cruz Rodríguez, A. Gutierrez Pérez, L. Chao García, D. Hernández Fernández, J. Raymond Pous, B. Sánchez Ramírez, C. Jacoberger-Foissac, H. Saliba, C. Seguin, A. Brion, B. Frisch, S. Fournel, B. Heurtault, T. Otterhaug, M. Håkerud, A. Nedberg, V. Edwards, P. Selbo, A. Høgset, T. Jaitly, J. Dörrie, N. Schaft, S. Gross, B. Schuler-Thurner, S. Gupta, L. Taher, G. Schuler, J. Vera, F. Rataj, F. Kraus, S. Grassmann, M. Chaloupka, S. Lesch, C. Heise, S. Endres, S. Kobold, B. M. Loureiro Cadilha, K. Dorman, C. Heise, F. Rataj, S. Endres, S. Kobold
  • Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer
    Andrea Ardizzoni, Sergio Azevedo, Belen Rubio-Viqueira, Delvys Rodríguez-Abreu, Jorge Alatorre-Alexander, Hans J M Smit, Jinming Yu, Konstantinos Syrigos, Kerstin Trunzer, Hina Patel, Jonathan Tolson, Andres Cardona, Pablo D Perez-Moreno, Tom Newsom-Davis
  • Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination
    Jun Gong, Thang Q. Le, Erminia Massarelli, Andrew E. Hendifar, Richard Tuli
  • Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab
    Andrew Hantel, Brooke Gabster, Jason X. Cheng, Harvey Golomb, Thomas F. Gajewski
  • Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy
    Guozhu Xie, Tan Cheng, Jie Lin, Lanfang Zhang, Jieling Zheng, Ying Liu, Guobo Xie, Baiyao Wang, Yawei Yuan
  • A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy
    Moshe C. Ornstein, Laura S. Wood, Brian P. Hobbs, Kimberly D. Allman, Allison Martin, Michael Bevan, Timothy D. Gilligan, Jorge A. Garcia, Brian I. Rini
  • Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance
    Marcus A. Couey, R. Bryan Bell, Ashish A. Patel, Meghan C. Romba, Marka R. Crittenden, Brendan D. Curti, Walter J. Urba, Rom S. Leidner
  • Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
    Yousef R. Badran, Justine V. Cohen, Priscilla K. Brastianos, Aparna R. Parikh, Theodore S. Hong, Michael Dougan
  • Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy
    Hao Liu, Zhen Zhao, Li Zhang, Yuanke Li, Akshay Jain, Ashutosh Barve, Wei Jin, Yanli Liu, John Fetse, Kun Cheng
  • Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)
    Anne Catherine Bretz, Ulrike Parnitzke, Kerstin Kronthaler, Tobias Dreker, René Bartz, Frank Hermann, Astrid Ammendola, Tanja Wulff, Svetlana Hamm

Pages